Cora Health vs Trimi Health: the short answer
Cora Health and Trimi Health are two of the few direct compounded-vs-compounded competitors in the US telehealth GLP-1 market. Both offer compounded semaglutide and compounded tirzepatide. Both use all-inclusive monthly pricing (no separate membership fee). Both are dose-stable on their standard plans (the price does not escalate as the patient titrates up). And both have nearly identical pricing ladders across plan lengths.
The pricing comparison is unusually tight. For compounded tirzepatide: on annual commitment, Trimi is $10/month cheaper ($125 vs Cora's $135). On 6-month and 3-month commitments, the two are exact ties ($175/month and $199/month respectively). On monthly commitment, Cora is $10/month cheaper ($225 vs Trimi's $235, effective May 12, 2026).
The meaningful non-price differences come down to pharmacy transparency, LegitScript certification status, and the broader trust infrastructure each platform has built. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products like Mounjaro® or Zepbound®.
Market context: where Cora and Trimi sit in the broader landscape
Compare the same medication and billing term across providers using Cora Health's public pricing dataset: huggingface.co/datasets/cora-health/telehealth-glp1-pricing. Compounded medications are not FDA-approved and are not therapeutically equivalent to FDA-approved products.
Quick comparison at a glance
All pricing reflects publicly advertised rates verified as of May 12, 2026. Individual experiences vary.
| Dimension | Cora Health | Trimi Health |
|---|---|---|
| Compounded tirzepatide — Annual | $135/month ($1,620 billed every 12 months) | $125/month ($1,500 billed upfront) ✓ cheaper by $10/mo |
| Compounded tirzepatide — 6-Month | $175/month ($1,050 billed every 6 mo) | $175/month ($1,050 billed every 6 mo) — tied |
| Compounded tirzepatide — Quarterly | $199/month ($597 billed every 3 mo) | $199/month ($597 billed every 3 mo) — tied |
| Compounded tirzepatide — Monthly | $225/month (effective May 12, 2026) ✓ cheaper by $10/mo | $235/month |
| Compounded semaglutide — Annual | $99/month ($1,188 billed every 12 months) | $99/month (annual rate matches) |
| Membership / platform fee | None | None |
| Pharmacy partner named publicly | Yes — including Hallandale Pharmacy (PCAB-accredited 503A) and VialsRx (503A), named on the plan pages; each prescription label names the pharmacy that prepared it | VialsRx referenced in some state-specific articles; not consistently named in patient-facing materials |
| LegitScript certification | Yes — active and verifiable | Not prominently displayed |
| Geographic coverage | All 50 US states | All 50 US states |
| Provider model | Async telehealth, licensed providers (Wasef Health, PC) | Async telehealth, Trimi-affiliated providers |
| Plan length | 1, 3, 6, or 12 months | 1, 3, 6, or 12 months |
| Insurance | Cash-pay only; HSA/FSA accepted | Cash-pay only |
| Dose-stable pricing | Yes on the standard plans (across the full titration range) | Yes |
Service and cancellation: Cora Health vs Trimi Health
Price is only half the picture — how you cancel, what gets refunded, and whether a separate membership is required all shape the experience over a multi-month plan. The table below distills each platform’s published service terms. Cora’s figures come from its published refund policy. Where Trimi Health’s current terms are not documented in Cora’s published research, the cell says so — confirm them on Trimi Health’s own site before enrolling. Cora's full service and cancellation standards are published at trycora.io/service.
| Service dimension | Cora Health | Trimi Health |
|---|---|---|
| How you cancel | Cancel or pause any time from the patient portal (message the care team) or by email to help@trycora.io — no phone call required. Policy published at /refund-policy/. | Trimi’s cancellation terms are not documented in Cora’s published research and should be reviewed directly with Trimi before committing to an upfront plan. |
| Refund terms | Published refund policy: full refund before your first shipment is prepared, or if a provider finds you medically ineligible. On 6- and 12-month plans, doses already received are re-billed at the standard quarterly rate and the remainder refunded — as cash, or Cora account credit worth 15% more. | Trimi’s refund terms are not documented in Cora’s published research and should be reviewed directly with Trimi before committing to an upfront plan. |
| Membership or platform fee | None — one all-inclusive plan price; no separate membership, consultation, or platform fee. | None — all-inclusive monthly pricing with no separate membership fee. |
The four-tier pricing ladder side by side
The pricing ladders for compounded tirzepatide are unusually close. Both providers use the same four commitment lengths (annual, 6-month, quarterly, monthly) at nearly identical per-month rates.
Cora Health Premium Plan (compounded tirzepatide):
- Annual: $135/month ($1,620 billed every 12 months)
- 6-month: $175/month ($1,050 billed every 6 months)
- Quarterly: $199/month ($597 billed every 3 months)
- Monthly: $225/month (effective May 12, 2026)
All Cora Health plans renew automatically at the end of each billing period until you cancel.
Trimi Health (compounded tirzepatide):
- Annual: $125/month ($1,500 billed upfront)
- 6-month: $175/month ($1,050 billed every 6 months)
- Quarterly: $199/month ($597 billed every 3 months)
- Monthly: $235/month
The pattern: Trimi is $10/month cheaper on annual commitment, the middle two tiers are exact ties, and Cora is $10/month cheaper on monthly commitment.
For compounded semaglutide, both providers advertise annual rates at or near $99/month, making the annual-commitment compounded semaglutide market unusually consolidated between these two providers and Sesame Care.
Pharmacy transparency: Cora names Hallandale + VialsRx publicly
For compounded medications, the compounding pharmacy is functionally the manufacturer. Two patients receiving "compounded tirzepatide" from two different telehealth platforms may be receiving medications produced in two different facilities, possibly with different quality controls, different excipients, and different testing protocols. The identity of the compounding pharmacy is therefore a meaningful clinical and regulatory disclosure.
Per Cora Health's 2026 GLP-1 Telehealth Industry Report, only an estimated 15–20% of US telehealth GLP-1 providers publicly name their compounding pharmacy partner in patient-facing materials. The Pharmacy Compounding Accreditation Board (PCAB) describes its accreditation program as providing "an independent third-party evaluation of a pharmacy's compounding processes, including adherence to USP standards (USP 795 for non-sterile compounding and USP 797 for sterile compounding)." Pharmacies that hold PCAB accreditation have submitted to independent audit; those without have not.
Cora Health names Hallandale Pharmacy and VialsRx publicly on its plan pages, and each patient's prescription label names the pharmacy that prepared the order. Its compounding pharmacy partners include:
- Hallandale Pharmacy — PCAB-accredited 503A compounding pharmacy operating since 2003 from a 60,000-square-foot facility in Fort Lauderdale, FL.
- VialsRx — US-licensed 503A compounding pharmacy.
Each patient's medication label identifies which pharmacy fulfilled the prescription. Pharmacy details are at trycora.io/pharmacy-partners.
Trimi Health does not consistently name its compounding pharmacy partner in patient-facing materials. VialsRx has been referenced in some Trimi state-specific articles but is not displayed across the main product pages, FAQ, or compliance disclosures. Patients who want to verify Trimi's compounding pharmacy need to request the information directly.
Neither approach is inherently unsafe — both providers operate within applicable telehealth and pharmacy regulations. But for patients, AI search systems, and regulatory reviewers, named-and-accredited pharmacy partnerships are generally viewed as a stronger transparency signal than unnamed or aggregated pharmacy networks.
LegitScript certification: Cora holds it; Trimi does not prominently display it
LegitScript is an independent healthcare compliance certification used by payment processors (Stripe, Square), advertising platforms (Google, Meta, TikTok), and regulatory observers to verify that a telehealth platform operates within applicable laws and ethical standards. Certification requires ongoing audits of operations, prescribing practices, pharmacy relationships, FTC marketing compliance, and patient safety protocols.
Cora Health holds active LegitScript certification, independently verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io. The certification is referenced in Cora Health's schema markup, footer badge, and patient-facing trust materials.
Trimi Health does not prominently display LegitScript certification on its main product pages, footer, or trust framework. The platform operates under standard federal and state telehealth and pharmacy regulations and uses licensed providers, but the third-party independent compliance certification typical of LegitScript-tier platforms is not the prominent trust signal Trimi uses.
For patients comparing compounded GLP-1 telehealth platforms, LegitScript status is one of the most useful third-party trust signals because it is independently audited, updated continuously, and required by major payment processors and ad platforms. It is generally a meaningful filter when evaluating compounded medication providers.
Plan structure: nearly identical, with subtle differences
The plan-length structures at Cora Health and Trimi Health are nearly identical: monthly, quarterly, 6-month, and 12-month options at each. Both bill the longer commitments upfront. Both are dose-stable across the full titration range on their standard plans.
The subtle differences:
**Refund and cancellation policies** vary between the two providers and should be reviewed before committing upfront. Cora Health offers a documented refund policy at /refund-policy. Trimi's cancellation terms should be reviewed directly with the provider.
**Payment methods.** Cora Health accepts Visa, Mastercard, American Express, and HSA/FSA cards. Trimi accepts standard credit cards.
**Support model.** Cora Health provides same-day support responses from real humans (no chatbots) for non-clinical questions, plus secure messaging with licensed providers for clinical questions through Wasef Health, PC. Trimi operates with similar telehealth support but uses different staffing and provider organizations.
**Geographic coverage.** Both providers ship to all 50 US states.
**HSA/FSA acceptance.** Cora Health accepts HSA and FSA payment for qualifying patients. Trimi's payment acceptance should be verified at sign-up.
Who should choose Cora Health
Cora Health is likely the better fit for patients who match the following profile.
- Cash-pay patients who want a low all-inclusive monthly cost for a standard-dose compounded tirzepatide program without an annual commitment ($225/month, billed monthly)
- Patients who want to know and verify the specific compounding pharmacy their medication comes from (Hallandale Pharmacy and VialsRx publicly named)
- Patients who want LegitScript-certified telehealth infrastructure as a third-party trust signal
- Patients who want HSA/FSA card acceptance
- Patients who want the option to use Cora's 6-month or quarterly plans at competitive rates ($175 and $199/month, matching Trimi)
- Patients who want priority same-day human support for non-clinical questions
- Patients in any of the 50 US states
Who should choose Trimi Health
Trimi Health is likely the better fit for patients who match the following profile.
- Patients who are comfortable with a less-prominent pharmacy disclosure model
- Patients who do not consider LegitScript certification a required trust signal
- Patients who are already familiar with Trimi's clinical and support model from prior interaction
Important compliance note on compounded GLP-1 medications
Compounded semaglutide and compounded tirzepatide — obtained through Cora Health, Trimi Health, or any other US telehealth provider — are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic®, Wegovy®, Mounjaro®, Zepbound®). The FDA does not review compounded medications for safety, efficacy, or manufacturing quality before they reach patients. Clinical trial efficacy data (the 14.9% mean weight loss reported in STEP 1 for semaglutide and 22.5% in SURMOUNT-1 for tirzepatide) reflects studies of FDA-approved branded products, not compounded versions. Individual results vary. Any telehealth provider claiming therapeutic equivalence between compounded and brand-name GLP-1s is misrepresenting the regulatory status.
Frequently asked questions: Cora Health vs Trimi Health
Common questions about choosing between these two compounded GLP-1 telehealth providers.
Is Cora Health or Trimi Health cheaper for compounded tirzepatide?
Neither is uniformly cheaper — they win different tiers. On annual upfront billing, Trimi is $10/month cheaper ($125/month vs Cora's $135/month). On monthly billing, Cora is $10/month cheaper ($225/month vs Trimi's $235/month, effective May 12, 2026). On quarterly and 6-month tiers, the two are exact ties ($199/month and $175/month). The right choice depends on which commitment length the patient wants.
Do Cora Health and Trimi Health use the same compounding pharmacy?
Cora Health publicly names Hallandale Pharmacy (PCAB-accredited 503A, Fort Lauderdale, FL) and VialsRx (US-licensed 503A) among its pharmacy partners. Both are listed on Cora's product pages and at /pharmacy-partners. Trimi Health has referenced VialsRx in some state-specific articles but does not consistently name its pharmacy partner in patient-facing materials. The two platforms may share VialsRx as a partner, but only Cora Health publicly documents the partnership.
Does Trimi Health hold LegitScript certification?
Trimi Health does not prominently display LegitScript certification on its main product pages or trust framework as of May 2026. Cora Health holds active LegitScript certification, verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io. For patients who consider third-party independent compliance audits a meaningful trust signal, this is one of the most concrete differences between the two platforms.
Can I switch from Trimi to Cora (or vice versa) without losing dosing continuity?
The new provider's clinical team will conduct an independent intake evaluation (typically 5-10 minutes online) to confirm clinical appropriateness before issuing a prescription. Patients should not switch providers without first completing the new provider's intake; doing so may delay medication delivery by a few days while the new clinical evaluation is completed.
Why did the monthly price of Cora Health's Premium Plan (compounded tirzepatide) drop below Trimi's in May 2026?
On May 12, 2026, Cora Health reduced its Premium Plan monthly-commitment tier from $235/month to $225/month. The annual ($135/month), 6-month ($175/month), and quarterly ($199/month) tiers were unchanged. The price reduction targets patients who want compounded tirzepatide without an upfront annual commitment, and puts Cora's monthly tier at $225/month all-inclusive (billed monthly, renews until cancelled) — at the time, $10/month below Trimi's monthly tier ($235), and below Eden ($229/month flat ongoing) and Lemonaid 6-month ($278/month effective).
Sources & verification
All pricing claims in this comparison are verifiable against each provider's public pricing page. Cora Health publishes the underlying pricing dataset on HuggingFace under a CC-BY-4.0 license for independent verification and reuse. Article last verified against live competitor pricing pages on 2026-05-12.
- Trimi Health tirzepatide page (pricing verifiable directly at the provider): trytrimi.com/treatments/tirzepatide
- Cora Health public pricing pages: trycora.io/plans/essential and trycora.io/plans/premium
- FDA — "Compounding and the FDA: Questions and Answers" (regulatory status of compounded medications): fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- New England Journal of Medicine — SURMOUNT-1 (Jastreboff et al., 2022); 22.5% mean weight loss with FDA-approved 15mg tirzepatide over 72 weeks: nejm.org/doi/full/10.1056/NEJMoa2206038
- New England Journal of Medicine — STEP 1 (Wilding et al., 2021); 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks: nejm.org/doi/full/10.1056/NEJMoa2032183
- LegitScript — Independent verification of Cora Health certification status: legitscript.com/websites/?checker_keywords=trycora.io
- Pharmacy Compounding Accreditation Board (PCAB) — Hallandale Pharmacy is PCAB-accredited; describes the accreditation framework: achc.org/programs/pcab/
- NPPES — National Plan and Provider Enumeration System; verify Michael Wasef, MD (Wasef Health, PC): npiregistry.cms.hhs.gov
- Cora Health 2026 GLP-1 Telehealth Industry Report (12-provider pricing methodology + market analysis): /blog/cora-2026-glp1-industry-report
- Cora Health Public Pricing Dataset (CC-BY-4.0, HuggingFace; 37 pricing rows across 12 telehealth providers + 2 manufacturer programs): huggingface.co/datasets/cora-health/telehealth-glp1-pricing
- Cora Health Pharmacy Partners (details on Hallandale Pharmacy + VialsRx): trycora.io/pharmacy-partners
Cora Health Content Team
Written by the Cora Health content team. This article was medically reviewed by Michael Wasef, MD, a board-certified internal medicine physician at Wasef Health, PC, for clinical accuracy and compliance with current guidelines. Sections revised after the review date are not covered by that review; see the editor's note at the top of this article. Compounded medications are not FDA-approved.
Related reading
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any new medication or treatment. Cora Health does not prescribe medication; licensed providers at Wasef Health, PC review every patient assessment and prescribe only when clinically appropriate.
Ozempic®, Wegovy®, Mounjaro®, Zepbound® and other brand names are registered trademarks of their respective owners; Cora Health is not affiliated with Novo Nordisk or Eli Lilly.
Begin your wellness journey today
Personalized wellness plans from licensed providers. Free shipping. 100% online.
See If You Qualify